Abbott Laboratories - Sale Or Purchase of Stock

Abbott Laboratories's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Sale-Or-Purchase-of-Stock" stands at -0.906 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 06/30/2021.

Abbott Laboratories's third quarter result of -0.305 Billion USD for the item "Sale Or Purchase of Stock" represents a decrease of -4,983.33 percent compared to it's second quarter result.

Also, Abbott Laboratories's third quarter result of -0.305 Billion USD for the item "Sale Or Purchase of Stock" represents an increase of 59.39 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Abbott Laboratories's third quarter result of -0.906 Billion USD for the item "Sale Or Purchase of Stock" represents an increase of 32.99 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.333 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.333 Billion United States Dollars.
The 3 year change is 3.18 Billion United States Dollars.
The 5 year change is -0.168 Billion United States Dollars.
The 10 year change is 0.444 Billion United States Dollars.

The Serie's long term average value is -1.49 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.582 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +3.42 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2017, to it's latest available value, on 09/30/2025, is -0.85 Billion.